Macquarie Group’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
NAMA
SCM
Macquarie Group's TWST Position: Q4 2025 in Review
Macquarie Group sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 82,248 shares — an estimated $2.31M sold.
Macquarie Group first reported a position in TWST in Q1 2020 and held it in 18 quarters. The position peaked at $17.6M in Q3 2021. 244 funds tracked by Wall St. Rank hold TWST as of Q4 2025.
- Macquarie Group reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
- Macquarie Group sold 82,248 Twist Bioscience shares in Q4 2025, an estimated $2.31M.
- Macquarie Group first reported a position in Twist Bioscience in Q1 2020 and held it in 18 quarters.
- Macquarie Group's Twist Bioscience position peaked at $17.6M in Q3 2021.
- 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.
Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.